At the 11th Munich Cancer Retreat (MCR11) on October 21 and 22, 2024, the DKTK partner site Munich prepared for the upcoming evaluation of the German Cancer Consortium (DKTK) end of 2025 and presented…
In the third DKTK School of Oncology Tech Talk of 2024 on Monday September 23th, Prof. Dr. Bettina Weigelin from the DKTK partner site Tübingen highlighted the role of microscopic imaging in…
For the eight-time, Cancer Core Europe hosted and organized its Summer School in Translational Cancer Research, bringing together a multidisciplinary group of junior investigators and clinicians eager…
How effective medications are depends on various factors, including the time of day when they are administered. Why? Because our bodies don’t always function exactly the same. Instead, they follow the…
The German Research Foundation (DFG) has awarded Reinhart Koselleck funding to two LMU scholars: leukemia specialist Irmela Jeremias, scientist of the German Cancer Consortium, partner site Munich,…
Glioblastomas are highly aggressive, usually incurable brain tumors. If all therapeutic options are exhausted, patients have an average life expectancy of less than two years. Now researchers from the…
The foundation Else Kröner-Fresenius-Stiftung (EKFS) announced the prizewinners of its Publication Prizes for this year. The distinction is honoring five research scientists, including three…
Multiple myeloma is one of the most common forms of cancer of the immune cells in the bone marrow. It is considered incurable. Even when patients respond to treatment at first, the cancer comes back.…
Dr. Heidi Altmann and Dr. Katja Steiger have taken over the management of the CCP-Bio (networked biobanking) from Prof. Michael Hummel within the DKTK Clinical Communication Platform (CCP) in the…
Research for health and the prevention and better treatment of common diseases are the goals of the German Centers for Health Research (DZG). At the 2nd DZG Munich Day on July 12, 2024, the eight DZG…
On Friday, June 7, this year’s Postdoc Symposium including the DKTK Young Academics Conference 2024 took place at the DKFZ Communication Center. The PDN-Committee, supported by the Postdoc Office and…
United against common diseases! This is the mission of the German Centers for Health Research (DZG). Their scientists are working to optimize the translation of research results into patient care,…
Cell-based cancer therapies often fail nowadaystoday because the immune cells are unable to penetrate the tumor efficiently. The use of certain phagocytes is considered a promising alternative - but…
Activated T cells that carry a certain marker protein on their surface are controlled by natural killer (NK) cells, another cell type of the immune system. In this way, the body presumably curbs…
Tumors actively prevent the formation of immune responses by so-called cytotoxic T cells, which are essential in combating cancer. Researchers at the Technical University of Munich (TUM) and the…
The European Research Council (ERC) supports visionary, ground-breaking research projects with its Advanced Grant. This year, the Council awarded the prestigious funding to the Neurologist Michael…
This year's winners of the Waltraud Lewenz Prize are a team of young scientists: Senior Postdoc Dr. Ashish Goyal (Heidelberg) together with his co-first authors PhD student Jens Bauer (Tübingen) and…
In the DKTK School of Oncology's first Tech Talk of 2024 on March 12, Dr. Christof Winter and PD Hedwig Deubzer discussed the benefits of Liquid Biopsies in pediatric and adult cancers.
150 representatives from six German Centers for Health Research (DZG) from the partner sites in Heidelberg and Mannheim met on February, 28 2024 for the first DZG Heidelberg-Mannheim Day. Overview…
The 6th Joint Dresden DZG Symposium took place on March 26, 2024: The three German Centers for Health Research (DZG) located in Dresden play a significant role on Dresden's biomedical campus, with 250…